Free Republic

I just watched a commercial for Prevnar 20 (i.e., PNC20, for pneumococcol pneumonia), which I believe failed to mention this product is made by Pfizer. It claimed people over 65 are 6x more likely to get pneumococcol pneumonia, but failed to note any other issues like co-morbidities which could contribute to this rate. Because there is sales pressure present, and by a company which cannot be trusted, I thought I would see what information might be available to a curious consumer.Here's Pfizer's webpage, noting that Prevnar was FDA approved June 08, 2021.U.S. FDA Approves PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate...

A new study led by researchers from Harvard School of Public Health (HSPH) and the Wellcome Trust Sanger Institute in the UK has, for the first time, used genome sequencing technology to track the changes in a bacterial population following the introduction of a vaccine. The study follows how the population of pneumococcal bacteria changed following the introduction of the 'Prevnar' conjugate polysaccharide vaccine, which substantially reduced rates of pneumococcal disease across the U.S. The work demonstrates that the technology could be used in the future to monitor the effectiveness of vaccination or antibiotic use against different species of bacterial...

Vaccine opponents, a scattered though potent force, have been gearing up in recent weeks to fight state health officials who are pushing for new immunization rules for babies and young children. This latest vaccine skirmish centers on proposals to require that young children in child care centers or preschool get vaccinated against both the flu and pneumonia. The shots would be for children over 6 months old and would include the pneumococcal conjugate vaccine (PCV7), and the influenza vaccine. Health officials said the mandates, not yet final, would prevent as many as 300 hospitalizations each year -- and possibly several...

NEW YORK (Reuters Health) - The supply issues with Prevnar, a vaccine that protects kids from bacterial infections, have been resolved and the Centers for Disease Control and Prevention and other groups are now recommending that doctors resume giving the full four doses of the vaccine, according to a report released Thursday. The vaccine helps build up the body's immune defenses against pneumococcus, a microbe that can cause pneumonia, middle ear infections and other serious infections. With the four-dose schedule, the vaccine is given to a child at 2, 4, and 6 months of age and then once again between...